Skip to content

Clinical trials

Phase 3 Rectal Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rectal Neoplasms Phase: Phase 3 Country / region: Germany Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20033
20041
20051
20061
20203
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting3
Unknown status2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC5
Pfizer2
Johann Wolfgang Goethe University Hospital1
Merck Sharp & Dohme LLC1
Mirati Therapeutics Inc.1
Nova Scotia Health Authority1
Novartis1
Novartis Pharmaceuticals1
Prof. Dr. med. Claus Rödel1
Ralf Hofheinz1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rectal Neoplasms19
Colorectal Neoplasms12
Colonic Neoplasms11
Neoplasm Metastasis2
Colonic Diseases1
Digestive System Diseases1
Digestive System Neoplasms1
Gastrointestinal Diseases1
Gastrointestinal Neoplasms1
Intestinal Diseases1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.